[Advances in pathophysiology, diagnosis and treatment of adult severe-associated thrombotic microangiopathy]

Hua Xu1, Yongqiang Wang, Hongmei Gao

  • 1Department of Critical Care Medicine, Tianjin First Center Hospital, Key Laboratory for Critical Care Medicine of the Ministry of Health, Emergency Medicine Research Institute, Tianjin 300192, China. Corresponding author: Gao Hongmei,

PubMed

Insights

Thrombotic microangiopathy (TMA) is a severe condition causing red blood cell destruction and low platelets. Prompt diagnosis and treatment are crucial for improving outcomes in adult patients.

Area of Science:

  • Hematology
  • Pathophysiology
  • Critical Care Medicine

Background:

  • Thrombotic microangiopathy (TMA) encompasses heterogeneous, severe syndromes.
  • Characterized by microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and end-organ ischemic injury.
  • TMA presents as a dangerous condition with high mortality and multi-organ involvement.

Approach:

  • This review synthesizes current knowledge on severe adult TMA.
  • Focuses on pathophysiological mechanisms.
  • Covers diagnostic and therapeutic strategies.

Key Points:

  • Severe TMA necessitates intensive care unit (ICU) support for organ function.
  • Early and rapid evaluation is critical for differential diagnosis.
  • Timely and effective treatment significantly impacts patient prognosis.

Conclusions:

  • Understanding TMA's complex pathophysiology is essential for effective management.
  • A systematic approach to diagnosis and treatment improves outcomes.
  • This review provides a comprehensive overview for clinicians managing severe adult TMA.